Stay updated on TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial
Sign up to get notified when there's something new on the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page.

Latest updates to the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page
- Check6 days agoChange DetectedThe study record page now displays a 403 Forbidden error, preventing access to the trial details and related documents. The page shows a 403 header with a generic footer, including a Home link.SummaryDifference19%

- Check13 days agoChange DetectedThe study record updates sponsor and collaborator information by adding Healx AI and noting Takeda’s divestment to Mistrau Bio, while older sponsor entries from 2021 were removed.SummaryDifference0.3%

- Check20 days agoChange DetectedAdded Tel Litwinsky, Ramat Gan, Israel, 52621 as a study location and added Ovid Therapeutics Inc. as a collaborator. Removed Qiryat Krinitzi, Ramat Gan, Israel, 52621 as a study location and Healx AI as a collaborator.SummaryDifference0.2%

- Check27 days agoChange DetectedTwo changes were made to the study locations: a new site at Qiryat Krinitzi, Ramat Gan, Israel, 52621 was added and the Tel Litwinsky, Ramat Gan, Israel, 52621 site was removed. The revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded a funding disclosure noting NIH support in 2018. This update reflects NIH grant/contract funding for the study.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, reflecting a small backend/template update with no noticeable changes to the displayed study details.SummaryDifference0.1%

Stay in the know with updates to TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page.